A quantity dispensed on a paid claim that is higher than the quantity written on the prescription is one of the easiest findings for a PBM auditor to prove, and one of the fastest to turn a routine fill into a recoupment demand. The finding, which auditors label as an overfill or an exceeds-quantity-limit discrepancy, sits inside the broader PBM audit landscape, and it flags a claim for a reason that has nothing to do with whether the patient needed the medication: the pharmacy billed more units than the prescriber authorized, or dispensed a manufacturer package that rounds above the written amount. A single flagged claim can be extrapolated across the audit lookback period into a recoupment demand that dwarfs the value of the original fill.
Overfill Findings Are Not Partial Fills or Quantity-Limit Flags
An overfill finding addresses the opposite problem from a partial fill: a partial fill means the pharmacy dispensed less than the prescribed quantity and billed the remainder later, while an overfill or exceeds-quantity-limit finding means the pharmacy billed more than the prescriber wrote. A quantity-limit flag is a third, different thing: it measures the dispensed amount against the health plan's benefit design, a ceiling the payer sets, not the prescription. The finding at issue here is narrower than either. It compares the billed or dispensed quantity directly against the written quantity, independent of plan limits and partial-fill timing. That narrow comparison is what makes the finding quick for an auditor to flag and, with the right record, quick for a pharmacy to rebut.
Manufacturer Package Sizes Push Billed Quantity Above the Written Amount
Manufacturer packaging produces overfill findings even when the pharmacy did nothing wrong. Insulin pens, inhalers, and other products ship in cartons that hold a fixed count, and a prescription written for a quantity that falls between two package sizes forces the pharmacist to either break open a carton labeled for single-patient use or round the billed quantity up to the next full package. Rounding up without a corresponding note on the prescription or in the dispensing record reads, on audit, exactly like an inflated quantity, because the auditor cannot see the packaging constraint that produced the difference unless the pharmacy's own file explains it.
Documentation That Supports the Dispensed Quantity
A PBM auditor comparing the written quantity to the billed quantity has no way to know why the two differ unless the pharmacy's own record supplies the reason first. The file should show the prescriber's authorization for a higher quantity, a contemporaneous dispensing note explaining a package-size rounding, and a wholesale invoice tying the dispensed National Drug Code back to the package actually purchased. Some states have written the package-size problem directly into statute. Oklahoma's Pharmacy Audit Integrity Act bars an auditor from writing up a claim as a discrepancy when the dispensed drug's National Drug Code is a subunit or multiple of the package purchased on the wholesale invoice, the pharmacy dispensed the quantity the prescription called for, and the dispensed National Drug Code shares all but its package-size digits with the invoiced National Drug Code (59 O.S. Section 356.2(B)(2), effective May 20, 2024). That protection is specific to Oklahoma and to states with comparable statutes; a pharmacy elsewhere still needs its own invoice-to-claim documentation to make the same argument to the auditor directly. A pharmacy also signs a separate yearly certification, its annual network attestation, which covers FWA training completion, exclusion screening, and license status rather than dispensing records.
An overfill finding compares two numbers on a page. Without the invoice and the prescriber's authorization in the file, the pharmacy has no way to show the auditor why they differ.
Why Early Legal Counsel Is Critical
It is critical that pharmacies promptly retain experienced healthcare defense counsel once a PBM audit begins flagging quantity discrepancies, rather than responding claim by claim without a coordinated strategy. Early legal intervention can identify which flagged claims are explained by package-size rounding rather than true overbilling, assemble the invoice and prescriber documentation before the response deadline, and address a payment hold the PBM imposes during the audit, a separate and often more urgent problem covered in Payment Holds During a PBM Audit. Delaying counsel until after a recoupment letter and a demand for network termination arrive narrows the options available at audit appeal.
How Health Law Alliance Can Help
Health Law Alliance's attorneys have overseen 2,000+ audits and handled 5,000+ matters, with 25+ years of experience.
Health Law Alliance's PBM audit defense attorneys review wholesale invoices, prescriptions, and dispensing records before an overfill finding is extrapolated into a full demand. If your pharmacy faces an overfill or exceeds-quantity-limit finding, contact our PBM audit defense team for a free, confidential consultation.





